Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/10851
Title: Fenfluramine augmentation of clomipramine treatment of obsessive compulsive disorder.
Austin Authors: Judd, F K;Chua, P;Lynch, C;Norman, Trevor R 
Affiliation: University of Melbourne, Department of Psychiatry, Austin Hospital, Heidelberg, Vic.
Issue Date: 1-Sep-1991
Publication information: The Australian and New Zealand Journal of Psychiatry; 25(3): 412-4
Abstract: Recently, much research interest has been directed to demonstrating a possible biological basis to obsessive compulsive disorder. In particular, dysregulation in brain serotonin is suggested to be important. Two cases are described in which fenfluramine, a presynaptic 5 HT-releasing agent and 5HT-reuptake inhibitor was used to augment clomipramine treatment for OCD.
Gov't Doc #: 1958165
URI: http://ahro.austin.org.au/austinjspui/handle/1/10851
URL: https://pubmed.ncbi.nlm.nih.gov/1958165
Type: Journal Article
Subjects: Adult
Clomipramine.administration & dosage
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Therapy, Combination
Female
Fenfluramine.administration & dosage
Humans
Obsessive-Compulsive Disorder.psychology.therapy
Appears in Collections:Journal articles

Show full item record

Page view(s)

4
checked on Nov 25, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.